Ikonisys SA (PA:ALIKO) — Market Cap & Net Worth
Market Cap & Net Worth: Ikonisys SA (ALIKO)
Ikonisys SA (PA:ALIKO) has a market capitalization of $21.30 Million (€18.22 Million) as of May 6, 2026. Listed on the PA stock exchange, this France-based company holds position #24812 globally and #405 in its home market, demonstrating a -3.45% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Ikonisys SA's stock price €1.40 by its total outstanding shares 13970094 (13.97 Million). Analyse cash efficiency ratio of Ikonisys SA to see how efficiently the company converts income to cash.
Ikonisys SA Market Cap History: 2021 to 2026
Ikonisys SA's market capitalization history from 2021 to 2026. Data shows change from $47.36 Million to $22.54 Million (-19.33% CAGR).
Ikonisys SA Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Ikonisys SA's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
24.07x
Ikonisys SA's market cap is 24.07 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2021 | $47.36 Million | $365.14K | -$571.27K | 129.71x | N/A |
| 2022 | $23.68 Million | $935.22K | -$2.45 Million | 25.32x | N/A |
| 2023 | $25.48 Million | $448.56K | -$2.27 Million | 56.80x | N/A |
| 2024 | $24.34 Million | $1.01 Million | -$3.24 Million | 24.07x | N/A |
Competitor Companies of ALIKO by Market Capitalization
Companies near Ikonisys SA in the global market cap rankings as of May 6, 2026.
Key companies related to Ikonisys SA by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #145 globally with a market cap of $152.22 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #211 globally with a market cap of $111.32 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #229 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
- Medtronic PLC (XETRA:2M6): Ranked #236 globally with a market cap of $101.71 Billion USD ( €87.00 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #145 | Abbott Laboratories | NYSE:ABT | $152.22 Billion | $87.54 |
| #211 | Stryker Corporation | NYSE:SYK | $111.32 Billion | $290.88 |
| #229 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
| #236 | Medtronic PLC | XETRA:2M6 | $101.71 Billion | €67.76 |
Ikonisys SA Historical Marketcap From 2021 to 2026
Between 2021 and today, Ikonisys SA's market cap moved from $47.36 Million to $ 22.54 Million, with a yearly change of -19.33%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €22.54 Million | -13.75% |
| 2025 | €26.13 Million | +7.38% |
| 2024 | €24.34 Million | -4.49% |
| 2023 | €25.48 Million | +7.59% |
| 2022 | €23.68 Million | -50.00% |
| 2021 | €47.36 Million | -- |
End of Day Market Cap According to Different Sources
On May 5th, 2026 the market cap of Ikonisys SA was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $21.30 Million USD |
| MoneyControl | $21.30 Million USD |
| MarketWatch | $21.30 Million USD |
| marketcap.company | $21.30 Million USD |
| Reuters | $21.30 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Ikonisys SA
Ikonisys S.A., a cell-based diagnostics company, develops, produces, and markets medical diagnostic products for early and accurate detection of cancer diseases in the United States and Europe. It offers Ikoniscope Robotic Microscopes, including Ikoniscope20 that provides automated slide handling, slide scanning, and real-time image capture and analysis; and Ikoniscope20max that automates the flu… Read more